Solara Active Pharma Sciences Limited (BOM:541540)

India flag India · Delayed Price · Currency is INR
499.60
+19.50 (4.06%)
At close: Feb 13, 2026
Market Cap24.07B -10.6%
Revenue (ttm)12.55B -4.2%
Net Income-191.10M
EPS-3.52
Shares Outn/a
PE Ration/a
Forward PE15.04
Dividendn/a
Ex-Dividend Daten/a
Volume12,155
Average Volume5,681
Open478.40
Previous Close480.10
Day's Range471.80 - 503.90
52-Week Range441.00 - 734.20
Betan/a
RSI43.97
Earnings DateFeb 6, 2026

About BOM:541540

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antif... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 2017
Employees 1,775
Stock Exchange Bombay Stock Exchange
Ticker Symbol 541540
Full Company Profile

Financial Performance

Financial Statements

News

Solara Active Pharma Sciences Ltd (BOM:541540) Q3 2026 Earnings Call Highlights: Strategic ...

Solara Active Pharma Sciences Ltd (BOM:541540) Q3 2026 Earnings Call Highlights: Strategic Shifts Amidst Ibuprofen Challenges

8 days ago - GuruFocus

Q3 2026 Solara Active Pharma Sciences Ltd Earnings Call Transcript

Q3 2026 Solara Active Pharma Sciences Ltd Earnings Call Transcript

8 days ago - GuruFocus

Solara Active Pharma’s Mangalore facility clears US FDA inspection with VAI classification

Solara Active Pharma Sciences Limited has received a positive regulatory update for its Mangalore manufacturing site, strengthening its position as...

3 months ago - Business Upturn

Solara Active Pharma Sciences Ltd (BOM:541540) Q2 2026 Earnings Call Highlights: Navigating ...

Solara Active Pharma Sciences Ltd (BOM:541540) Q2 2026 Earnings Call Highlights: Navigating Challenges with Strategic Debt Reduction and Market Expansion

3 months ago - GuruFocus

Q2 2026 Solara Active Pharma Sciences Ltd Earnings Call Transcript

Q2 2026 Solara Active Pharma Sciences Ltd Earnings Call Transcript

3 months ago - GuruFocus

Solara Active Pharma shares slump nearly 9% today after reporting Q2 net loss

Shares of Solara Active Pharma Sciences Ltd plunged 8.77% to Rs 563.00 in early trade on Thursday after the company...

3 months ago - Business Upturn

Solara Active Pharma shares rise 4% after Ambernath facility clears USFDA inspection with zero observations

Shares of Solara Active Pharma Sciences Ltd surged nearly 4% to ₹523.35 on Monday after the company announced that its Ambernath manufacturing facility in Maharashtra has successfully cleared a US Foo...

9 months ago - Business Upturn

Solara Active Pharma shares down 5% as Managing Director Poorvank Purohit resigns

Shares of Solara Active Pharma Sciences Ltd declined 5% in early trade on February 24, following the announcement of Managing Director (MD) and CEO Poorvank Purohit’s resignation. The stock dropped to...

1 year ago - Business Upturn

Solara Active Pharma Sciences announces demerger of CRAMS and Polymers business

Solara Active Pharma Sciences has announced the demerger of its CRAMS (Contract Research and Manufacturing Services) and Polymers business from the Generic API business (Catalog API). The move is expe...

1 year ago - Business Upturn

Solara Active Pharma Sciences Q3 FY25 Results: Revenue up 41.6% YoY to Rs 300.31 crore

Solara Active Pharma Sciences Limited announced its financial results for the quarter ended December 31, 2024, showing a consistent performance across key financial metrics. Key Financial Highlights: ...

1 year ago - Business Upturn